Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-02
1998-12-08
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
058469770
ABSTRACT:
Nerve growth factor production accelerating agents containing oxazopyrroloquinolines, pyrroquinolinequinones and/or their esters as active ingredient are provided. As the oxazopyrroloquinolines and their esters exhibit such production accelerating activity, they are suitably utilized for preventing and treating functional disorders of central nervous system, particularly, Alzheimer's dementia, cerebral ischemia and spinal trauma, as well as for functional disorders of peripheral nervous system, particularly, peripheral nervous system trauma and diabetic neurosis. As the pyrroquinolinequinones and their esters exhibit strong nerve growth factor production accelerating activity, they are suitably utilized for preventing and treating functional disorders of peripheral nervous system, particularly, peripheral nervous system trauma, diabetic neurosis, etc.
REFERENCES:
patent: 4898870 (1990-02-01), Narutomi et al.
patent: 5061711 (1991-10-01), Urakami et al.
Kondo Kiyosi
Tsuji Tomoko
Urakami Teizi
Yamaguchi Kohji
Fay Zohreh
Mitsubishi Gas Chemical Company
Moezie M.
Sagami Chemical Research Center
LandOfFree
Nerve growth factor production accelerators and compositions for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nerve growth factor production accelerators and compositions for, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nerve growth factor production accelerators and compositions for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177518